4//SEC Filing
Bumpus John P 4
Accession 0001225208-18-004984
CIK 0001301611other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:55 PM ET
Size
14.8 KB
Accession
0001225208-18-004984
Insider Transaction Report
Form 4
Bumpus John P
EVP, Chief Admin. Officer
Transactions
- Award
Non-Qualified Stock Options (Right to buy)
2018-02-27+47,706→ 47,706 totalExercise: $44.85Exp: 2028-02-27→ Common (47,706 underlying) - Tax Payment
Common
2018-02-28$46.10/sh−3,610$166,421→ 116,086 total - Exercise/Conversion
Common
2018-02-27+9,200→ 119,696 total - Exercise/Conversion
Restricted Stock Units
2018-02-27−9,200→ 27,471 totalExercise: $0.00→ Common (9,200 underlying) - Award
Restricted Stock Units
2018-02-27+15,743→ 36,671 totalExercise: $0.00→ Common (15,743 underlying)
Holdings
- 1,455(indirect: By Spouse)
Common
- 851(indirect: By Retirement Plan)
Common
Footnotes (4)
- [F1]Pursuant to the terms of the Company's 2013 Long-Term Incentive Plan, these shares were automatically withheld for payment of the tax liability incident to the vesting of a restricted stock award.
- [F2]The options vest in four equal installments beginning on the first anniversary of the date of grant.
- [F3]The Performance Period with respect to these restricted stock units ("RSUs") is January 1, 2018 through December 31, 2020. Each RSU represents the right to receive, upon vesting, up to two shares of the Issuer's common stock. Vesting of these performance-based RSUs is contingent upon the achievement of annually established performance targets for diluted earnings per share for each of the three fiscal years of the Performance Period, with the final number of shares of common stock issued under the RSUs subject to modification based on the Issuer's three-year annualized total shareholder return as of December 31, 2020 relative to the S&P GICS Sub-Industry Health Care Facilities with over $500 million in revenues, or its equivalent. Any RSUs earned during the Performance Period will be paid out 75% in 2020 and 25% in 2021, contingent upon continued employment with the Issuer.
- [F4]Vesting of these performance-based RSUs was contingent upon the Issuer's three-year annualized total shareholder return or TSR as of December 31, 2017 relative to the S&P GICS Sub-industry: Health Care Facilities with over $500 million in revenues, or its equivalent.
Documents
Issuer
LIFEPOINT HEALTH, INC.
CIK 0001301611
Entity typeother
Related Parties
1- filerCIK 0001422311
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 5:55 PM ET
- Size
- 14.8 KB